BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 31533007)

  • 1. Case studies in neuroscience: a novel amino acid duplication in the NH
    Angus M; Peters CH; Poburko D; Brimble E; Spelbrink EM; Ruben PC
    J Neurophysiol; 2019 Nov; 122(5):1975-1980. PubMed ID: 31533007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
    J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective Na
    Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
    Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
    Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
    Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
    Sun Y; Paşca SP; Portmann T; Goold C; Worringer KA; Guan W; Chan KC; Gai H; Vogt D; Chen YJ; Mao R; Chan K; Rubenstein JL; Madison DV; Hallmayer J; Froehlich-Santino WM; Bernstein JA; Dolmetsch RE
    Elife; 2016 Jul; 5():. PubMed ID: 27458797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
    Miller AR; Hawkins NA; McCollom CE; Kearney JA
    Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome.
    Kwong AK; Fung CW; Chan SY; Wong VC
    PLoS One; 2012; 7(7):e41802. PubMed ID: 22848613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
    Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA
    Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
    Lopez-Santiago L; Isom LL
    Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies.
    Mei D; Cetica V; Marini C; Guerrini R
    Epilepsia; 2019 Dec; 60 Suppl 3():S2-S7. PubMed ID: 31904125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular analysis of epilepsy-related genes in patients with Dravet syndrome.
    Jiang T; Shen Y; Chen H; Yuan Z; Mao S; Gao F
    Medicine (Baltimore); 2018 Dec; 97(50):e13565. PubMed ID: 30558019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two mild cases of Dravet syndrome with truncating mutation of SCN1A.
    Takaori T; Kumakura A; Ishii A; Hirose S; Hata D
    Brain Dev; 2017 Jan; 39(1):72-74. PubMed ID: 27544716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent behavioral abnormalities in a Scn1a
    Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
    Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the likelihood of SCN1A microdeletions or duplications in Dravet syndrome with missense mutation.
    Shi X; Wang J; Kurahashi H; Ishii A; Higurashi N; Kaneko S; Hirose S
    Brain Dev; 2012 Sep; 34(8):617-9. PubMed ID: 22206733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
    Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
    J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
    Bayat A; Hjalgrim H; Møller RS
    Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation in GABRB3 associated with Dravet syndrome.
    Le SV; Le PHT; Le TKV; Kieu Huynh TT; Hang Do TT
    Am J Med Genet A; 2017 Aug; 173(8):2126-2131. PubMed ID: 28544625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo, in vitro and in silico correlations of four de novo SCN1A missense mutations.
    Nissenkorn A; Almog Y; Adler I; Safrin M; Brusel M; Marom M; Bercovich S; Yakubovich D; Tzadok M; Ben-Zeev B; Rubinstein M
    PLoS One; 2019; 14(2):e0211901. PubMed ID: 30735520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.